Similar Articles
New Treatment Strategies in the Treatment of Juvenile Idiopathic Arthritis
İbrahim GÖKÇE, Erkan DEMİRKAYA
DOI: 10.5606/tjr.2011.012
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience
Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN
DOI: 10.5606/ArchRheumatol.2014.3855
A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents
Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS
DOI: 10.5606/ArchRheumatol.2015.4383
Immunoglobulin G4-Related Disease in The Head and Neck: Two Case Reports and Literature Review
Morteza MAZLOUM FARSI BAF, Maryam SAHEBARI, Kamran KHAZAENI, Zahra REZAIEYAZDI
DOI: 10.5606/ArchRheumatol.2015.5105
Parkinsonism as a Manifestation of Neuropsychiatric Systemic Lupus Erythematosus: A Case Report and Literature Review
Qi TANG, Jing WANG, Jinwei CHEN, Xi XIE, Jing TIAN
DOI: 10.5606/ArchRheumatol.2015.5456
Longitudinal Myelitis of a Neuro-Behçet Patient
Qi TANG, Jing TIAN
DOI: 10.5606/ArchRheumatol.2016.5441
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients Without Traditional Cardiovascular Risk Factors
Hector MACIAS-REYES, Sergio DURAN-BARRAGAN, Cynthia R. CARDENAS-CONTRERAS, Cesar G. CHAVEZ-MARTIN, Eduardo GOMEZ-BAÑUELOS, Rosa E. NAVARRO-HERNANDEZ, Carlos O. YANOWSKY-GONZALEZ, Laura GONZALEZ-LOPEZ, Jorge I. GAMEZ-NAVA, Monica VAZQUEZ-DEL MERCADO
DOI: 10.5606/ArchRheumatol.2016.5739
Mikulicz’s Disease With Immune Thrombocytopenia: A New Immunoglobulin G4-Mediated Disorder and Literature Review
Shu LI, Cong DENG, Jinwei CHEN, Fen LI
DOI: 10.5606/ArchRheumatol.2019.7070
Efficacy of Combination Therapy With Pirfenidone and Low-Dose Cyclophosphamide for Refractory Interstitial Lung Disease Associated With Connective Tissue Disease: A Case-Series of Seven Patients
Lichong SHEN, Qingran YAN, Xiaoxiang CHEN
DOI: 10.46497/ArchRheumatol.2020.7381
Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies
Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA
DOI: 10.46497/ArchRheumatol.2020.7498
Immunoglobulin G4-Related Mastitis: An Unusual Case of Recurrent Breast Abscess
Shruti BAJAD, Dhaval TANNA, Gayatri EKBOTE, Muzaffar BINDROO, Kanchan KAUR, Rajiva GUPTA
DOI: 10.46497/ArchRheumatol.2020.7567
Unusual presentation of immunoglobulin G4-related disease: A case report
Gözde ZEYBEK, Sevinç KALIN, Burcu KARAKAYALI, Ebru ZEMHERİ, Sait NADERİ, Betül SÖZERİ5
DOI: 10.46497/ArchRheumatol.2021.7550
Hearing loss can also be seen in patients with nonradiographic axial spondyloarthropathies as well as radiographic axial spondyloarthropathies
Hanife Çağlar Yağcı, İlker Yağcı, Osman İlkay Özdamar, Cansu Tosyalı Salman, Özlem Ertuğrul
DOI: 10.46497/ArchRheumatol.2023.10186
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2023.10199
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556